Literature DB >> 23646488

[Preliminary study of establishing clinical effect evaluation methods of Chinese medicine based on combination of disease and syndrome, systematic staging, and multi-dimension index].

Wang Xian-liang1, Mao Jing-yuan, Hou Ya-zhu.   

Abstract

The clinical effect evaluation of Chinese medicine (CM) has been the bottleneck restricting its development. Based on the current situation, in this study, we integrated and combined previous results of clinical effect evaluation of CM, and proposed the clinical effect evaluation method of CM based on combination of disease and syndrome, systematic staging, and multi-dimension index. We also made a specific exposition on the connotation, establishment methods and practice of the clinical effect evaluation methods of CM based on combination of disease and syndrome, systematic staging, and multi-dimension index.

Mesh:

Year:  2013        PMID: 23646488

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  4 in total

Review 1.  Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials.

Authors:  Jing Hu; Shuo Liu; Weihong Liu; Huina Zhang; Jing Chen; Hongcai Shang
Journal:  Ann Transl Med       Date:  2017-11

2.  Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.

Authors:  Chunxiang Liu; Yazhu Hou; Xianliang Wang; Zhiqiang Zhao; Zhi Liu; Jingbo Zhai; Jingyuan Mao; Hongcai Shang
Journal:  Trials       Date:  2015-05-21       Impact factor: 2.279

3.  Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.

Authors:  Ying Tian; Junhua Zhang; Yingqiang Zhao; Jingyuan Mao; Linping Zhu; Rui Gao; Xuemei Wang; Mingjun Zhu; Lihong Ma; Mengyu Zhao; Wenke Zheng
Journal:  Trials       Date:  2018-10-20       Impact factor: 2.279

Review 4.  The Use of Multiple Primary Outcomes in Randomized Controlled Trials of Chinese Herbal Medicine.

Authors:  Jing Hu; Shuo Feng; Xiaoli Zhang; Huina Zhang; Yanxiang Ha; Chongyang Wei; Xuejiao Wang; Rui Zhang; Xing Liao; Bo Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-21       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.